Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection.
about
Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine developmentVirulence and Fitness Determinants of Uropathogenic Escherichia coliCrystal structure of c5321: a protective antigen present in uropathogenic Escherichia coli strains displaying an SLR foldVirulence characteristics and genetic affinities of multiple drug resistant uropathogenic Escherichia coli from a semi urban locality in IndiaDirected evaluation of enterotoxigenic Escherichia coli autotransporter proteins as putative vaccine candidates.UpaH is a newly identified autotransporter protein that contributes to biofilm formation and bladder colonization by uropathogenic Escherichia coli CFT073In silico design of fusion protein of FimH from uropathogenic Escherichia coli and MrpH from Proteus mirabilis against urinary tract infectionsGenomic evidence for the emergence and evolution of pathogenicity and niche preferences in the genus Campylobacter.Mucosal immunization with iron receptor antigens protects against urinary tract infection.Towards a vaccine against Escherichia coli-associated urinary tract infections.The innate immune response to uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infectionHost imprints on bacterial genomes--rapid, divergent evolution in individual patientsUrine sample preparation in 96-well filter plates for quantitative clinical proteomics.Escherichia coli global gene expression in urine from women with urinary tract infection.Genome sequence of adherent-invasive Escherichia coli and comparative genomic analysis with other E. coli pathotypesIdentification of in vivo-induced antigens including an RTX family exoprotein required for uropathogenic Escherichia coli virulence.Survival of uropathogenic Escherichia coli in the murine urinary tract is dependent on OmpREnterotoxigenic Escherichia coli elicits immune responses to multiple surface proteins.A multiepitope subunit vaccine conveys protection against extraintestinal pathogenic Escherichia coli in mice.Physiological and proteomic analysis of Escherichia coli iron-limited chemostat growth.Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration.Occurrence of virulence genes associated with diarrheagenic Escherichia coli isolated from raw cow's milk from two commercial dairy farms in the Eastern Cape Province, South Africa.Immunoproteomic analysis to identify Shiga toxin-producing Escherichia coli outer membrane proteins expressed during human infection.Jenner-predict server: prediction of protein vaccine candidates (PVCs) in bacteria based on host-pathogen interactions.Host-specific induction of Escherichia coli fitness genes during human urinary tract infection.Presence of putative repeat-in-toxin gene tosA in Escherichia coli predicts successful colonization of the urinary tract.In vitro activity of commercial probiotic Lactobacillus strains against uropathogenic Escherichia coli.Polymicrobial interactions: impact on pathogenesis and human disease.Intracellular Uropathogenic E. coli Exploits Host Rab35 for Iron Acquisition and Survival within Urinary Bladder CellsBack to the metal age: battle for metals at the host-pathogen interface during urinary tract infection.Escherichia coli isolates that carry vat, fyuA, chuA, and yfcV efficiently colonize the urinary tractNovel vaccine antigen combinations elicit protective immune responses against Escherichia coli sepsis.Transcriptomics and adaptive genomics of the asymptomatic bacteriuria Escherichia coli strain 83972.Development of a Vaccine against Escherichia coli Urinary Tract Infections.Outer membrane antigens of the uropathogen Proteus mirabilis recognized by the humoral response during experimental murine urinary tract infection.Trade-off between iron uptake and protection against oxidative stress: deletion of cueO promotes uropathogenic Escherichia coli virulence in a mouse model of urinary tract infectionEscherichia coli O157:H7 survives within human macrophages: global gene expression profile and involvement of the Shiga toxinsImmunization with the yersiniabactin receptor, FyuA, protects against pyelonephritis in a murine model of urinary tract infection.Colibacillosis in poultry: unravelling the molecular basis of virulence of avian pathogenic Escherichia coli in their natural hosts.Urothelial cultures support intracellular bacterial community formation by uropathogenic Escherichia coli
P2860
Q21328677-30FB6A94-9606-4990-86F9-B329B35AC5ECQ26782598-658CEC77-FD77-45C3-BC4D-2A0E2227CBC9Q27680157-60E5FDED-88A7-4ABB-B70B-5C7736D5AFE8Q28477517-2C1CDB54-EE5D-44C3-A5AD-5C1228A62EE1Q30155406-7727C68F-67A2-40F2-928C-0F6051907718Q30156964-0F38EAE0-0E72-4D0F-8C8D-EB91E1C5FA99Q30381843-A12076BC-FE11-4F7A-A514-5E5DF0A69F70Q30847855-EC11C1B6-7718-427B-BAA1-6EAC9DAF9206Q33508792-22FFF7B8-3392-46EC-BE45-40F80CA12582Q33538262-04B99AEA-ACCA-4210-8DB3-27373106F653Q33652449-91B00D60-18E4-482C-8981-ED2FC67F66B7Q33701690-5BB3BBB7-40D5-40CC-9870-8886316684BEQ33710494-D3063B3D-AEC5-4194-B823-5EACFFA56D89Q33750030-172FEC0F-DFED-4926-A827-60CCA6DE5EC6Q33756129-78D2E348-9C0D-4382-B83E-E7068A87DBD1Q33851098-8139CCEA-6BF8-4E62-B1DB-8C72BD93902EQ33923814-EA1B21ED-4A23-4AF6-971D-8D15453004A4Q33963134-B9865015-65E9-47FC-AA20-4979920D260CQ34045099-9DA4FF0C-4E62-43E9-9B9A-058AE691E7C4Q34056844-DF41483A-F8B4-43CD-9F8C-CFAEE540AB42Q34113328-61285071-2AE6-4FEE-81C1-47611F6A0032Q34578486-9F99B1FD-F3E1-4392-9501-50628AA344ACQ34596249-BD6268E4-6FDD-47EA-8BBB-A15C7BD55932Q34787708-F07E0139-6D17-4773-BC9F-F5A24C8C966DQ34793116-85EB56CB-C4BD-4F9A-8C74-308E5A56D4B7Q34931344-4B76FB5F-BA40-497A-A9DA-5C12C2FA2056Q35664689-20D66746-E98B-4B94-A582-991D133FEF11Q35666253-3EEA5F37-8C3D-48EB-83C0-A2294B73D4C3Q35738930-D50A40F1-C52D-4B67-91A2-3D8BC20662F3Q36251958-D7D7AC08-B5B2-42A8-B347-C92D43F2D1CAQ36396881-6454ABFD-A2A8-4A11-BB4E-C2C6AE34FEE5Q36471330-D77A5C2C-2CFB-4F1A-B32C-81B5313AF96EQ36579494-0426A345-A790-4580-9F5F-3DE66BED6002Q36735378-57D984EA-964C-4960-9641-85268561465AQ36845213-65A30420-48AF-40CA-899C-CEE020E83078Q36933772-2861A4E0-20EB-41C4-98A1-DC5A98731437Q36949983-F8417BD8-7553-4DE1-8211-0B28B34DDB5EQ37123720-ABB2F134-70D3-4449-8118-BFDE8719052DQ37214790-3575EB00-F878-44A8-90F8-72B732DC2A94Q37256577-43D32DBC-3B6F-4F04-BC22-AB5BE7C33B6F
P2860
Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Uropathogenic Escherichia coli ...... uring urinary tract infection.
@ast
Uropathogenic Escherichia coli ...... uring urinary tract infection.
@en
type
label
Uropathogenic Escherichia coli ...... uring urinary tract infection.
@ast
Uropathogenic Escherichia coli ...... uring urinary tract infection.
@en
prefLabel
Uropathogenic Escherichia coli ...... uring urinary tract infection.
@ast
Uropathogenic Escherichia coli ...... uring urinary tract infection.
@en
P2860
P356
P1476
Uropathogenic Escherichia coli ...... uring urinary tract infection.
@en
P2093
Erin C Hagan
P2860
P304
P356
10.1128/IAI.00337-07
P407
P577
2007-05-21T00:00:00Z